US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

LEGN Legend Biotech Corporation

43.74

-1.40 (-3.10%)

30 Abr 2024 - Cerrado

Retrasado por 15 minutos

Form 144/A - Report of proposed sale of securities: [Amend]

Legend Biotech (NASDAQ:LEGN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Haga Click aquí para más Gráficas Legend Biotech.

Legend Biotech (NASDAQ:LEGN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024

Haga Click aquí para más Gráficas Legend Biotech.

Noticias sobre Legend Biotech Corporation LEGN

CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Lunes 22 de Abril 2024 (1 semana hace) • Business Wire

Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results
Jueves 11 de Abril 2024 (3 semanas hace) • Business Wire

Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma
Viernes 5 de Abril 2024 (4 semanas hace) • Business Wire

Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report
Martes 19 de Marzo 2024 (1 mes hace) • Business Wire

CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Viernes 15 de Marzo 2024 (2 meses hace) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lunes 11 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
Lunes 11 de Marzo 2024 (2 meses hace) • Business Wire

U.S. Index Futures Dip Ahead of Inflation Data and Oracle’s Earnings; Oil Prices Edge Higher
Lunes 11 de Marzo 2024 (2 meses hace) • IH Market News

Form 144/A - Report of proposed sale of securities: [Amend]
Miércoles 28 de Febrero 2024 (2 meses hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Martes 27 de Febrero 2024 (2 meses hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Viernes 23 de Febrero 2024 (2 meses hace) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Viernes 23 de Febrero 2024 (2 meses hace) • Edgar (US Regulatory)

Más de Legend Biotech Corporation Artículos de Noticias

US Dollar vs MXN

Financial Select Sector

Verizon Communications

Health Care Select Sector

BNP Paribas (QX)

Energy Select Sector SPDR

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones